These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1830376)

  • 1. [Prothrombotic and prethrombotic markers in obese diabetic and non-diabetic subjects].
    Ferlito S; Di Mauro V; Palermo A; Mazzone D; Condorelli M; Papalia D
    Minerva Cardioangiol; 1991; 39(1-2):21-8. PubMed ID: 1830376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemostatic parameters in patients with type IIA and IV hyperlipoproteinemia].
    Ferlito S; Torrisi A; Marangio S; Palermo A; Condorelli M; Mazzone D
    Minerva Cardioangiol; 1992 Jun; 40(6):211-7. PubMed ID: 1407615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fibrinogen and antithrombin III in obese subjects].
    Ferlito S; Palermo A; Mazzone D; Condorelli M; Papalia D
    Minerva Endocrinol; 1990; 15(2):145-8. PubMed ID: 2098657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood coagulation and fibrinolysis in obese NIDDM patients.
    Avellone G; Di Garbo V; Cordova R; Rotolo G; Abruzzese G; Raneli G; De Simone R; Bompiani GD
    Diabetes Res; 1994; 25(2):85-92. PubMed ID: 7648783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemostatic balance in patients with acute focal cerebral vasculopathy.
    Ferlito S; Condorelli M; Mazzone D
    Panminerva Med; 1994 Dec; 36(4):184-7. PubMed ID: 7603735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of body weight on insulin activity].
    Sindelka G; Skrha J; Prázný M; Hilgertová J
    Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The thrombophilic status and ischemic cardiopathy].
    Ferlito S; Torrisi A; Marangio S; Palermo A; Condorelli M; Mazzone D
    Minerva Cardioangiol; 1991 May; 39(5):167-76. PubMed ID: 1956544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an oral fat load on some prothrombotic markers in coronary heart patients.
    Ferlito S; Di Mauro C
    Panminerva Med; 1990; 32(3):101-4. PubMed ID: 2077474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
    De Pergola G; Pannacciulli N; Coviello M; Scarangella A; Di Roma P; Caringella M; Venneri MT; Quaranta M; Giorgino R
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):227-32. PubMed ID: 17400434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent and opposite associations of hip and waist circumference with metabolic syndrome components and with inflammatory and atherothrombotic risk factors in overweight and obese women.
    Rocha PM; Barata JT; Teixeira PJ; Ross R; Sardinha LB
    Metabolism; 2008 Oct; 57(10):1315-22. PubMed ID: 18803932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk factors in obese women and their first-degree relatives.
    Saraç F; Ozgen AG; Yilmaz C; Tüzün M
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Panminerva Med; 1998 Dec; 40(4):304-8. PubMed ID: 9973826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Minerva Endocrinol; 1999; 24(3-4):117-21. PubMed ID: 10953727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antithrombin III in the Senegalese diabetic].
    Thiam D; Belem WC; Ndiaye MF; Diakhate L; Sow AM
    Dakar Med; 1990; 35(2):193-7. PubMed ID: 2135794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [TNF-alpha and carbohydrate and lipid parameters in overweight and obese children].
    Goral J
    Ann Acad Med Stetin; 2008; 54(2):14-21. PubMed ID: 19374226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM; Barrow BA; Grant PJ; Levy JC
    Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.